Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84

Ao, Mei; Venkatasubramanian, Jayashree; Boonkaewwan, Chaiwat; Ganesan, Nivetha; Syed, Asma; Benya, Richard; Rao, Mrinalini; Benya, Richard V; Rao, Mrinalini C
February 2011
Digestive Diseases & Sciences;Feb2011, Vol. 56 Issue 2, p339
Academic Journal
journal article
Background: Lubiprostone, used clinically (b.i.d.) to treat constipation, has been reported to increase transepithelial Cl(-) transport in T84 cells by activating ClC-2 channels.Aim: To identify the underlying signaling pathway, we explored the effects of short-term and overnight lubiprostone treatment on second messenger signaling and Cl(-) transport.Methods: Cl(-) transport was assessed either as I(sc) across T84 monolayers grown on Transwells and mounted in Ussing chambers or by the iodide efflux assay. [cAMP](i) was measured by enzyme immunoassay, and [Ca(2+)](i) by Fluo-3 fluorescence. Quantitation of apical cell surface CFTR protein levels was assessed by Western blotting and biotinylation with the EZ-Link Sulfo-NHS-LC-LC-Biotin. ClC-2 mRNA level was studied by RT-PCR.Results: Lubiprostone and the cAMP stimulator, forskolin, caused comparable and maximal increases of I(sc) in T84 cells. The I(sc) effects of lubiprostone and forskolin were each suppressed if the tissue had previously been treated with the other agent. These responses were unaltered even if the monolayers were treated with lubiprostone overnight. Lubiprostone-induced increases in iodide efflux were ~80% of those obtained with forskolin. Lubiprostone increased [cAMP](i). H89, bumetanide, or CFTR(inh)-172 greatly attenuated lubiprostone-stimulated Cl(-) secretion, whereas the ClC-2 inhibitor CdCl(2) did not. Compared to controls, FSK-treatment increased membrane-associated CFTR by 1.9 fold, and lubiprostone caused a 2.6-fold increase in apical membrane CFTR as seen by immunoblotting following cell surface biotinylation.Conclusions: Lubiprostone activates Cl(-) secretion in T84 cells via cAMP, protein kinase A, and by increasing apical membrane CFTR protein.


Related Articles

  • Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. Liu, Shi-Quan; Huang, Jie-An; Qin, Meng-Bin; Su, Ying-Jie; Lai, Ming-Yu; Jiang, Hai-Xing; Tang, Guo-Du // International Journal of Colorectal Disease;Dec2012, Vol. 27 Issue 12, p1569 

    Purpose: Sphingosine kinase (SphK) 1 is an oncogenic enzyme promoting transformation, proliferation, and survival of a number of human tumor cells. However, its effect on colon cancer cell behavior has not been fully clarified. Methods: SphK1 plasmid or SphK1 shRNA transfection and N,...

  • CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling. Al-haidari, Amr; Syk, Ingvar; Jirström, Karin; Thorlacius, Henrik // International Journal of Colorectal Disease;Nov2013, Vol. 28 Issue 11, p1479 

    Background: Accumulating data suggest a role of chemokines in tumor cell metastasis. CCR4 has been implicated in hematologic malignancies and recently also in solid tumors. Herein, we hypothesized that CCR4 might be expressed and support migration of colon cancer cells. Methods: We used...

  • Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer. Yang, Shao-Bo; Du, Yun; Wu, Ben-Yan; Xu, Shi-Ping; Wen, Jun-Bao; Zhu, Min; Cai, Chang-Hao; Yang, Ping-Chang // Cancer Immunology, Immunotherapy;Mar2012, Vol. 61 Issue 3, p335 

    Tumor immune tolerance plays a critical role in tumor cell survival; the establishment of tumor immune tolerance is incompletely understood yet. Integrin alphavbeta6 (avb6) is involved in tumor growth and metastasis. This study aimed to observe the effect of avb6 on the development of tumor...

  • Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis. Garcia, Vanesa; Garcia, Jose M.; Silva, Javier; Peña, Cristina; Dominguez, Gemma; Lorenzo, Yolanda; Diaz, Raquel; Alonso, Isabel; Colas, Antonio; Hurtado, Alicia; Sanchez, Antonio; Bonilla, Felix // Journal of Cancer Research & Clinical Oncology;Nov2008, Vol. 134 Issue 11, p1165 

    The regulator of angiogenesis most extensively studied is VEGF. VEGF mRNA in plasma from patients with colorectal cancer was analyzed as a possible surrogate marker of tumor angiogenesis. VEGF mRNA was measured by quantitative PCR in plasma, tumors and circulating tumor cells from colorectal...

  • OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain. Bressan, Alessandro; Bozzo, Francesca; Maggi, Carlo Alberto; Binaschi, Monica // Disease Markers;2013, Vol. 34 Issue 4, p257 

    The human cancer antigen 125 (CA125) is over-expressed in epithelial ovarian cancer cells and it plays a role in the pathogenesis of ovarian cancer. This protein presents a repeat region containing up to sixty tandem repeat units. The anti-CA125 monoclonal antibodies have been previously...

  • Helicobacter pylori-infected MSCs acquire a pro-inflammatory phenotype and induce human gastric cancer migration by promoting EMT in gastric cancer cells. QIANG ZHANG; JUAN DING; JINJUN LIU; WEI WANG; FENG ZHANG; JUNHE WANG; YUYUN LI // Oncology Letters;Jan2016, Vol. 11 Issue 1, p449 

    Accumulating clinical and experimental evidence has suggested that Helicobacter pylori (H. pylori) infection-associated gastric cancer (GC) is associated with high rates of mortality and serious health effects. The majority of patients succumb to H. pylori infection-associated GC due to...

  • Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. Cohen, Sharon; Bruchim, Ilan; Graiver, Dror; Evron, Zoharia; Oron-Karni, Varda; Pasmanik-Chor, Metsada; Eitan, Ram; Bernheim, Joelle; Levavi, Hanoch; Fishman, Ami; Flescher, Eliezer // Journal of Molecular Medicine;Mar2013, Vol. 91 Issue 3, p357 

    Ovarian carcinoma patients are initially responsive to platinum-based therapy, but eventually become refractory to treatment due to the development of platinum chemoresistance. Elevated levels of interleukin-6 (IL-6) in the sera and ascites of these patients predict poor clinical outcome. Our...

  • Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells. Andoh, Akira; Shimada, Mitsue; Araki, Yoshio; Fujiyama, Yoshihide; Bamba, Tadao // Cancer Immunology, Immunotherapy;Feb2002, Vol. 50 Issue 12, p663 

    Decay-accelerating factor (DAF) expressed on the surface of colonic cancer cells presents a barrier to complement-mediated clearance by contributing to the ineffectiveness of the humoral immune response. In this study, to investigate the mechanisms responsible for the anti-tumor effects of...

  • Reduced NGF Secretion by HT-29 Human Colon Cancer Cells Treated with a GRPR Antagonist. de Farias, Caroline Brunetto; Stertz, Laura; Lima, Rodrigo Cruz; Kapczinski, Flávio; Schwartsmann, Gilberto; Roesler, Rafael // Protein & Peptide Letters;Jun2009, Vol. 16 Issue 6, p650 

    The gastrin-releasing peptide receptor (GRPR) is a therapeutic target in colon cancer. Here we show that the GRPR antagonist RC-3095 (10-3, 10-6, or 1 µM) decreases nerve growth factor (NGF) secretion measured by enzyme-linked immunosorbent assay (ELISA) in HT-29 human colon carcinoma cells....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics